Thermo Fisher beats fourth-quarter expectations, shares climb

Investing.com -- Shares in Thermo Fisher Scientific climbed in premarket trading Thursday after the medical equipment maker reported better-than-expected fourth-quarter results.

The company posted earnings per share (EPS) of $6.57, exceeding analyst expectations of $6.45, as revenue rose 7% year over year to $12.21 billion, above the consensus forecast of $11.89 billion.

Organic revenue growth for the quarter was 3%, the company said.

The stock rose 1.4% in premarket trading by 06:08 ET.

"Thanks to our exceptional team, we delivered a strong finish to 2025, reflecting outstanding execution and the continued strength of our proven growth strategy,” said Marc Casper, chairman, president and CEO of Thermo Fisher Scientific.

“We enter 2026 from a position of strength. Our growth strategy is resonating with customers, positioning us for continued share gain, and our PPI Business System provides a strong foundation to continue our excellent operational performance."

Adjusted operating income reached $2.88 billion in the fourth quarter of 2025, up 6% from the prior year, while the adjusted operating margin edged down to 23.6% from 23.9% a year earlier.

The company said it will outline its financial outlook for 2026 during its earnings conference call scheduled for 8:30 am ET.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• Sigma Lithium resumes full operations after signing TAC agreement
• OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises